Functional and genetic characterization of the promoter region of apolipoprotein H (β2-glycoprotein I)

FEBS Journal

Volumn 277, Issue 4, 2010, Pages 951-963

  Suresh, Sangita ^a   Demirci, F Yesim ^a   Lefterov, Iliya ^b   Kammerer, Candace M ^a   Ramsey Goldman, Rosalind ^c   Manzi, Susan ^d   Kamboh, M Ilyas ^a  

^a GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

2 glycoprotein I; APOH; Association; Polymorphisms; Promoter

Indexed keywords

BETA2 GLYCOPROTEIN 1; CIS ACTING ELEMENT; LUCIFERASE;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOMIC FRAGMENT; HAPLOTYPE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ANIMALS; BASE SEQUENCE; BETA 2-GLYCOPROTEIN I; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HEP G2 CELLS; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REFERENCE STANDARDS;

EID: 76149146003     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07538.x     Document Type: Article

References (22)

1. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335, 1544 1547.
2. McNeil HP, Simpson RJ, Chesterman CN Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87, 4120 4124.
3. Okkels H, Rasmussen TE, Sanghera DK, Kamboh MI Kristensen T (1999) Structure of the human beta2-glycoprotein I (apolipoprotein H) gene. Eur J Biochem 259, 435 440.
4. Sheng Y, Sali A, Herzog H, Lahnstein J Krilis SA (1996) Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 157, 3744 3751.
5. Sanghera DK, Wagenknecht DR, McIntyre JA Kamboh MI (1997) Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 6, 311 316.
6. Mehdi H, Naqvi A Kamboh MI (2000) A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding. Eur J Biochem 267, 1770 1776.
7. Wang HH Chiang AN (2004) Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity. Biochem J 380, 455 463.
8. Averna M, Paravizzini G, Marino G, Lanteri E, Cavera G, Barbagallo CM, Petralia S, Cavallaro S, Magro G, Grasso S et al. (1997) Liver is not the unique site of synthesis of beta 2-glycoprotein I (apolipoprotein H): evidence for an intestinal localization. Int J Clin Lab Res 27, 207 212.
9. Polz E Kostner GM (1979) The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett 102, 183 186.
10. Gambino R, Ruiu G, Pagano G Cassader M (1999) The binding of apolipoprotein H (beta2-glycoprotein I) to lipoproteins. Prostaglandins Other Lipid Mediat 57, 351 359.
11. Àar C, de Groot PG, Levels JH, Marquart JA Meijers JC (2009) Beta2-glycoprotein I is incorrectly named apolipoprotein H. J Thromb Haemost 7, 235 236.
12. Kamboh MI, Manzi S, Mehdi H, Fitzgerald S, Sanghera DK, Kuller LH Atson CE (1999) Genetic variation in apolipoprotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus. Lupus 8, 742 750.
13. Rahgozar S, Giannakopoulos B, Yan X, Wei J, Cheng Qi J, Gemmell R Krilis SA (2008) Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2- glycoprotein I autoantibodies. Arthritis Rheum 58, 1146 1155.
14. Mehdi H, Aston CE, Sanghera DK, Hamman RF Kamboh MI (1999) Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet 105, 63 71.
15. Mehdi H, Manzi S, Desai P, Chen Q, Nestlerode C, Bontempo F, Strom SC, Zarnegar R Kamboh MI (2003) A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem 270, 230 238.
16. Chen Q Kamboh MI (2006) Complete DNA sequence variation in the apolipoprotein H (beta-glycoprotein I) gene and identification of informative SNPs. Ann Hum Genet 70, 1 11.
17. Suresh S, Demirci FY, Jacobs E, Kao AH, Rhew EY, Sanghera DK, Selzer F, Sutton-Tyrrell K, McPherson D, Bontempo FA et al. (2009) Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes. J Rheumatol 36, 315 322.
18. Quandt K, Frech K, Karas H, Wingender E Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23, 4878 4884.
19. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR O'Donovan MC (2003) Functional analysis of human promoter polymorphisms. Hum Mol Genet 12, 2249 2254.
20. Noda C Ichihara A (1993) Regulation of liver-specific gene expression. Cell Struct Funct 18, 189 194.
21. Pattison S, Skalnik DG Roman A (1997) CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5′ end of the human papillomavirus type 6 long control region. J Virol 71, 2013 2022.
22. Cooper SJ, Trinklein ND, Anton ED, Nguyen L Myers RM (2006) Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. Genome Res 16, 1 10.